Correlation Between Viridian Therapeutics and Akoya Biosciences
Can any of the company-specific risk be diversified away by investing in both Viridian Therapeutics and Akoya Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Viridian Therapeutics and Akoya Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Viridian Therapeutics and Akoya Biosciences, you can compare the effects of market volatilities on Viridian Therapeutics and Akoya Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Viridian Therapeutics with a short position of Akoya Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Viridian Therapeutics and Akoya Biosciences.
Diversification Opportunities for Viridian Therapeutics and Akoya Biosciences
0.69 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Viridian and Akoya is 0.69. Overlapping area represents the amount of risk that can be diversified away by holding Viridian Therapeutics and Akoya Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Akoya Biosciences and Viridian Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Viridian Therapeutics are associated (or correlated) with Akoya Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Akoya Biosciences has no effect on the direction of Viridian Therapeutics i.e., Viridian Therapeutics and Akoya Biosciences go up and down completely randomly.
Pair Corralation between Viridian Therapeutics and Akoya Biosciences
Given the investment horizon of 90 days Viridian Therapeutics is expected to generate 0.54 times more return on investment than Akoya Biosciences. However, Viridian Therapeutics is 1.84 times less risky than Akoya Biosciences. It trades about -0.1 of its potential returns per unit of risk. Akoya Biosciences is currently generating about -0.16 per unit of risk. If you would invest 2,328 in Viridian Therapeutics on August 28, 2024 and sell it today you would lose (225.00) from holding Viridian Therapeutics or give up 9.66% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Viridian Therapeutics vs. Akoya Biosciences
Performance |
| Timeline |
| Viridian Therapeutics |
| Akoya Biosciences |
Viridian Therapeutics and Akoya Biosciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Viridian Therapeutics and Akoya Biosciences
The main advantage of trading using opposite Viridian Therapeutics and Akoya Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Viridian Therapeutics position performs unexpectedly, Akoya Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Akoya Biosciences will offset losses from the drop in Akoya Biosciences' long position.| Viridian Therapeutics vs. Nuvalent | Viridian Therapeutics vs. Arcellx | Viridian Therapeutics vs. Vaxcyte | Viridian Therapeutics vs. Crinetics Pharmaceuticals |
| Akoya Biosciences vs. AtriCure | Akoya Biosciences vs. ICU Medical | Akoya Biosciences vs. Haemonetics | Akoya Biosciences vs. AngioDynamics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |